tiprankstipranks
Protara Therapeutics (TARA)
NASDAQ:TARA
Holding TARA?
Track your performance easily

Protara Therapeutics (TARA) Income Statement

578 Followers

Protara Therapeutics Income Statement

Last quarter (Q2 2024), Protara Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Protara Therapeutics's net income was $-9.51M. See Protara Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
------
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 20.55M$ 43.61M$ 37.55M$ 47.49M$ 34.44M$ 7.83M
Operating Income
$ -44.25M$ -43.61M$ -67.06M$ -47.49M$ -34.44M$ -7.83M
Net Non Operating Interest Income Expense
$ 3.56M$ -3.18M$ -1.09M$ 237.00K$ 466.00K$ 262.00K
Other Income Expense
$ 372.00K$ 12.00K$ -29.50M$ 1.50M$ -500.00K-
Pretax Income
$ -16.99M$ -40.42M$ -65.95M$ -47.25M$ -33.98M$ -7.83M
Tax Provision
$ -13.75M$ -13.75M$ -9.02M$ -8.92M$ -8.65M$ 2.54M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -40.69M$ -40.42M$ -65.95M$ -47.25M$ -33.98M$ -7.83M
Basic EPS
$ -3.19$ -3.57$ -5.86$ -4.21$ -4.70$ -30.15
Diluted EPS
$ -3.19$ -3.57$ -5.86$ -4.21$ -4.70$ -30.15
Basic Average Shares
$ 55.37M$ 11.33M-$ 11.23M$ 7.23M$ 497.27K
Diluted Average Shares
$ 55.37M$ 11.33M$ 11.26M-$ 7.23M$ 497.27K
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 20.55M$ 43.61M$ 37.55M$ 47.49M$ 34.44M$ 7.83M
Net Income From Continuing And Discontinued Operation
$ -40.69M$ -40.42M$ -65.95M$ -47.25M$ -33.98M$ -7.83M
Normalized Income
$ -33.41M$ -54.18M----
Interest Expense
------
EBIT
$ -18.65M$ -43.61M$ -64.81M$ -45.52M$ -33.94M$ -7.83M
EBITDA
$ -17.87M$ -43.27M$ -64.57M$ -45.40M$ -33.84M$ -7.81M
Currency in USD

Protara Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis